Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2254
Título : Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment.
Autor : Horrillo, A
Pezzolla, D
Fraga, M F
Aguilera, Y
Salguero-Aranda, C
Tejedo, J R
Martin, F
Bedoya, F J
Soria, B
Hmadcha, A
Filiación: [Horrillo,A; Pezzolla,P; Aguilera,Y; Soria,B; Hmadcha,A] Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)– Fundación Progreso y Salud, Sevilla, Spain. [Pezzolla,P; Salguero-Aranda,C; Tejedo,JR; Martin,F; BedoyaFJ; Soria,B; Hmadcha,A] CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. [Fraga,MF] Department of Epigenetic, Oncologic Institute of Principado of Asturias, Oviedo, Spain. [Salguero-Aranda,C; Tejedo,JR; Martin,F; BedoyaFJ] Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) – University of Pablo de Olavide, Sevilla, Spain
Palabras clave : Embryonic stem cells
Methylation
Mesoderm
Zebularine
AzadC
Nitric oxide
Células madre embrionaria
Metilación
Mesodermo
Línea celular
MeSH: Medical Subject Headings::Chemicals and Drugs::Biological Factors::Biomarkers
Medical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Differentiation
Medical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line
Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Ribonucleosides::Cytidine
Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::DNA Methylation
Medical Subject Headings::Anatomy::Cells::Stem Cells::Embryonic Stem Cells::Embryoid Bodies
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Expression Profiling
Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Gene Expression Regulation, Developmental
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Phenomena and Processes::Metabolic Phenomena::Metabolism::Metabolic Networks and Pathways
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice
Medical Subject Headings::Anatomy::Cells::Muscle Cells::Myocytes, Cardiac
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Nucleic Acid Amplification Techniques::Polymerase Chain Reaction::Real-Time Polymerase Chain Reaction
Fecha de publicación : 4-Apr-2013
Editorial : Nature Publishing Group
Cita Bibliográfica: Horrillo A, Pezzolla D, Fraga MF, Aguilera Y, Salguero-Aranda C, Tejedo JR, et al. Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment. Cell Death Dis; 4:e570
Abstract: Lineage commitment during embryonic stem cell (ESC) differentiation is controlled not only by a gamut of transcription factors but also by epigenetic events, mainly histone deacetylation and promoter DNA methylation. The DNA demethylation agent 5'-aza-2'-deoxycytidine (AzadC) has been widely described as an effective promoter of cardiomyogenic differentiation in various stem cell types. However, its toxicity and instability complicate its use. Therefore, the purpose of this study was to examine the effects of zebularine (1-(β-D-ribofuranosyl)-1,2-dihydropyrimidin-2-1), a stable and non-toxic DNA cytosine methylation inhibitor, on mouse ESC (mESC) differentiation. Herein, we report that treating embryoid bodies, generated from mESCs, with 30 μM zebularine for 7 days led to greater cell differentiation and induced the expression of several cardiac-specific markers that were detected using reverse transcription-polymerase chain reaction (RT-PCR), real-time PCR, immunostaining and flow cytometry. Zebularine enhanced the expression of cardiac markers and the appearance of beating cells that responded to cardiac drugs, including ion channel blockers (diltiazem) and β-adrenergic stimulators (isoproterenol). Gene promoter methylation status was assessed using methylation-specific PCR (MSP) and validated by bisulfite sequencing analysis. Global gene expression profiling using microarrays showed that zebularine-differentiated cells are distinct from control ESCs. Pathway analysis revealed an enhancement of cellular processes such as embryonic development, cardiovascular system development and function. In addition, the whole-cell proteins exhibited different profiles as analyzed by two-dimensional differential-in-gel-electrophoresis. Our results indicate that zebularine regulates mesodermal differentiation of mESCs, controls promoter methylation of crucial cardiac genes and may help to improve cardiomyogenic differentiation.
Descripción : Journal Article; Research Support, Non-U.S. Gov't;
URI: http://hdl.handle.net/10668/2254
Versión del editor : http://www.nature.com/cddis/journal/v4/n4/full/cddis201388a.html
DOI: 10.1038/cddis.2013.88
ISSN : 2041-4889 (Online)
Appears in Collections:01- Artículos - CABIMER. Centro Andaluz de Biología Molecular

Files in This Item:
File Description SizeFormat 
Horrillo_Zebularine.pdfArtículo publicado3,26 MBAdobe PDFView/Open
Horrillo_Zebularine_Movie1.aviVideo 1114,24 MBAudio Video Interleave FileView/Open
Horrillo_Zebularine_Movie2.aviVideo 281,6 MBAudio Video Interleave FileView/Open
Horrillo_Zebularine_Movie3.aviVideo 397,92 MBAudio Video Interleave FileView/Open
Horrillo_Zebularine_T1.pdfTabla 1110,88 kBAdobe PDFView/Open
Horrillo_Zebularine_T2.xlsTabla 2241,5 kBMicrosoft ExcelView/Open
Horrillo_Zebularine_T2Legend.docTabla 2 _Texto21,5 kBMicrosoft WordView/Open


This item is licensed under a Creative Commons License Creative Commons